Use of fluoroquinolones as prophylactic agents in patients with neutropenia.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  The Pediatric Infectious Disease Journal

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00006454-199701000-00038PMID 9002124
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial.

  2020cited by this paper
• Relation between the faecal concentration of various potentially pathogenic microorganisms and infections in individuals (mice) with severely decreased resistance to infection

  2004cited by this paper
• Bacteremia due to viridans streptococcus in neutropenic patients with cancer: clinical spectrum and risk factors.

  1994cited by this paper
• Colonization resistance

  1994cited by this paper
• Septicemia and shock syndrome due to viridans streptococci: a case-control study of predisposing factors.

  1992cited by this paper
• Prevention of bacterial infection in neutropenic patients with hematologic malignancies. A randomized, multicenter trial comparing norfloxacin with ciprofloxacin. The GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.

  1991cited by this paper
• Drug interactions with fluoroquinolones.

  1991cited by this paper
• Prophylaxis of bacterial infections with ciprofloxacin in patients undergoing bone marrow transplantation.

  1991cited by this paper
• Safety of ciprofloxacin in children: Worldwide clinical experience based on compassionate use. Emphasis on joint evaluation

  1991cited by this paper
• Fluoroquinolone antimicrobial agents.

  1991cited by this paper
• Ofloxacin versus vancomycin/polymyxin for prevention of infections in granulocytopenic patients.

  1990cited by this paper
• Ofloxacin versus co-trimoxazole for prevention of infection in neutropenic patients following cytotoxic chemotherapy

  1990cited by this paper
• The contribution of Escherichia coli to microbial colonization resistance.

  1990cited by this paper
• Prophylactic co-trimoxazole versus norfloxacin in neutropenic children — perspective randomized study

  1989cited by this paper
• Fluoroquinolone antimicrobial agents

  1989cited by this paper
• Selective decontamination of the digestive tract: general principles.

  1988cited by this paper
• Comparison of norfloxacin with cotrimoxazole for infection prophylaxis in acute leukemia. The trade-off for reduced gram-negative sepsis.

  1988cited by this paper
• Proceeings of the 4th EOTRC Breast Cancer Working Conference. London, 1-3 July 1987.

  1988cited by this paper
• The 4th EORTC Breast Cancer Working Conference, London, 1–3 July 1987

  1988cited by this paper
• Infection prophylaxis in acute leukemia: a comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin.

  1987cited by this paper
• Long-term prophylaxis of infection by selective decontamination in leukopenia and in mechanical ventilation.

  1987cited by this paper
• Norfloxacin versus vancomycin/polymyxin for prevention of infections in granulocytopenic patients.

  1986cited by this paper
• Ciprofloxacin for selective decontamination of the alimentary tract in patients with acute leukemia during remission induction treatment: the effect on fecal flora.

  1985cited by this paper
• Selective antimicrobial modulation as prophylaxis against infection during granulocytopenia: trimethoprim-sulfamethoxazole vs. nalidixic acid.

  1983cited by this paper
• Pharmacokinetics and tissue penetration of ciprofloxacin

  1983cited by this paper
• Trimethoprim/sulfamethoxazole prophylaxis in neutropenic patients. Reduction of infections and effect on bacterial and fungal flora.

  1983cited by this paper
• Oral antibiotic prophylaxis in patients with cancer: a double-blind randomized placebo-controlled trial.

  1983cited by this paper
• Failure of oral trimethoprim-sulfamethoxazole prophylaxis in acute leukemia: isolation of resistant plasmids from strains of Enterobacteriaceae causing bacteremia.

  1982cited by this paper
• A prospective controlled investigation of prophylactic trimethoprim/sulfamethoxazole in hospitalized granulocytopenic patients.

  1979cited by this paper
• Introduction to mechanisms of association of indigenous microbes.

  1979cited by this paper
• Successful chemoprophylaxis for Pneumocystis carinii pneumonitis.

  1977cited by this paper
• Infection prevention in acute nonlymphocytic leukemia. Laminar air flow room reverse isolation with oral, nonabsorbable antibiotic prophylaxis.

  1975cited by this paper
• Human fecal flora: the normal flora of 20 Japanese-Hawaiians.

  1974cited by this paper
• A controlled study of isolation and endogenous microbial suppression in acute myelocytic leukemia patients

  1973cited by this paper
• Origin of infection in acute nonlymphocytic leukemia. Significance of hospital acquisition of potential pathogens.

  1972cited by this paper
• Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia.

  1966cited by this paper

• Prophylactic fluoroquinolones in hematopoietic stem cell transplant recipients: A meta-analytic comparison of ciprofloxacin and levofloxacin

  2025cites this paper
• Fluoroquinolone prophylaxis in autologous hematopoietic stem cell transplant recipients

  2017cites this paper
• The complexity of aging: cancer risk among elderly people and infectious risk among those with cancer.

  2013cites this paper
• Dose escalation of intravenous irinotecan using oral cefpodoxime: A phase I study in pediatric patients with refractory solid tumors

  2012cites this paper
• Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy.

  2012cites this paper
• [Typhlitis: report of a case and review of the literature].

  2008cites this paper
• Typhlite : à propos d’une observation et revue de la littérature

  2008cites this paper
• Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy.

  2005cites this paper
• Emergence of quinolone resistance among viridans group streptococci isolated from the oropharynx of neutropenic peripheral blood stem cell transplant patients receiving quinolone antimicrobial prophylaxis

  2005cites this paper
• Prophylactic application of fluoroquinolones for selective decontamination of the gut: friend or foe

  2005cites this paper
• Early bacteremia in pediatric hematopoietic stem cell transplant patients on oral antibiotic prophylaxis

  2005cites this paper
• Meta-Analysis: Antibiotic Prophylaxis Reduces Mortality in Neutropenic Patients

  2005cites this paper
• Fluoroquinolone antibiotics in infants and children.

  2005cites this paper
• Apparent failure of moxifloxacin to prevent ciprofloxacin- and levofloxacin-susceptible Pseudomonas aeruginosa bacteremia in neutropenic patients undergoing peripheral blood stem cell transplantation.

  2004cites this paper
• Quinolones in Pediatrics

  2003cites this paper
• Fluoroquinolones in paediatrics: a risk for the patient or for the community?

  2003cites this paper
• Tratamiento ambulatorio secuencial parenteral-oral de niños con neutropenia y fiebre de bajo riesgo de mortalidad #

  2003cites this paper
• Nuevas y viejas quinolonas.

  2002cites this paper
• The battle against emerging antibiotic resistance: should fluoroquinolones be used to treat children?

  2002cites this paper
• Selective Bowel Decontamination for the Prevention of Infection in Acute Myelogenous Leukemia: A Prospective Randomized Trial

  2002cites this paper
• Fluoroquinolones in Paediatrics

  2001cites this paper
• Chemoprophylaxe bakterieller Infektionskrankheiten in der pädiatrischen Onkologie

  2001cites this paper
• Les fluoroquinolones en pédiatrie

  2001cites this paper
• [Antimicrobial prophylaxis of bacterial infections in pediatric oncology patients].

  2001cites this paper
• Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia

  2001cites this paper
• Duration of Penicillin Prophylaxis in Sickle Cell Anemia: Issues and Controversies

  2000cites this paper
• Typhlitis complicating autologous blood stem cell transplantation for breast cancer

  2000cites this paper
• Use of the Quinolones in Pediatrics

  2000cites this paper
• [Antiinfectious prophylaxis in pediatric oncology. Work group "Quality Assurance" of Society for Pediatric Oncology and Hematology (GPOH)].

  1999cites this paper
• Reflections on gut decontamination in hematology.

  1999cites this paper
• The use of fluoroquinolones in pediatrics—A reassessment

  1999cites this paper
• Diez pautas básicas para el manejo del paciente oncológico con neutropenia y fiebre

  1999cites this paper
• The prophylaxis of bacterial infections in neutropenic patients.

  1999cites this paper
• Die antiinfektiöse Prophylaxe in der pädiatrischen Onkologie

  1999cites this paper